PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment
Gail B Cross, Intan P Sari, Sarah M Burkill, Chee Woei Yap, Han Nguyen, Do Quyet, Victoria B Dalay, Emmanuel Gutierrez, Vincent M Balanag, Randy J Castillo, Christina C Chang, Anthony D Kelleher, Jim O’Doherty, Nicholas I Paton · 2024
Read PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment by Gail B Cross, Intan P Sari, Sarah M Burkill, Chee Woei Yap, Han Nguyen, Do Quyet, Victoria B Dalay, Emmanuel Gutierrez, Vincent M Balanag, Randy J Castillo, Christina C Chang, Anthony D Kelleher, Jim O’Doherty, Nicholas I Paton (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11611914.txt.
Description
Cross and co-authors use PET-CT scans to check whether a statin add-on changes tuberculosis lung disease. The main trial found rosuvastatin added nothing to standard TB care on microbe or X-ray outcomes. A sub-study scanned 24 patients with a sugar tracer that lights up active tissue. Scans ran at the start and at week eight. Measures included uptake levels, active volume, and cavity size.
Total lesion activity fell by about two thirds in both groups. The statin group's median drop was 65.8%, the standard group's 64.3%. Cavity shrinkage also matched closely. Imaging thus backs the main verdict: no extra benefit from the statin.
Catalog record
| CREATOR | Gail B Cross, Intan P Sari, Sarah M Burkill, Chee Woei Yap, Han Nguyen, Do Quyet, Victoria B Dalay, Emmanuel Gutierrez, Vincent M Balanag, Randy J Castillo, Christina C Chang, Anthony D Kelleher, Jim O’Doherty, Nicholas I Paton |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |